# Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids

> **NCT06786780** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Chongqing University Cancer Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Cervical Cancer Treated with Pelvic Radiotherapy
- Cervical Cancers

## Interventions

- **COMBINATION_PRODUCT:** Drug: Cisplatin

## Key facts

- **NCT ID:** NCT06786780
- **Lead sponsor:** Chongqing University Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-01-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06786780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06786780, "Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06786780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*